Haolic

No usable evidence was supplied to identify Haolic as a commercial brand, company, product platform, retailer, or trademark. The only source provided (E1) is a press release about Debiopharm's MultiLINK antibody-drug-conjugate linker technology and contains no mention of Haolic, so it cannot support any brand claims. Because the name could equally refer to a non-brand namesake, a dormant or unregistered mark, or a private venture with no public footprint, this entry is deliberately kept minimal rather than filled with speculative details. No founding year, headquarters, ownership, product line, executive, or market position can be attributed to Haolic on the available evidence. The entry is flagged for review so that a future pass can attach a verified official website, registry filing, or Wikipedia brand-sense article before any substantive dossier is written.

• 2026.10.14

  Reported2026.10.14

  Haolic launches third-generation XP-2 Desktop DTF Printer[2]Haolic发布第三代XP-2桌面DTF打印机finanznachrichten.de

  Haolic, a brand specializing in direct-to-film (DTF) and UV DTF printing equipment, announced on October 14, 2026 the launch of the third-generation Haolic XP-2 Desktop DTF Printer, a 13-inch model introducing touchscreen-controlled pinch roller lifting, automatic film cutting, improved ink management, automated maintenance features and upgraded mechanical components. The printer, developed using customer feedback, became available for purchase beginning October 15, 2026 through Haolic's official website.

Read more

1. 1Debiopharm's Pre-Clinical Proof-Of-Concept Research Unveils the Potential of Novel MultiLINK Linker Technology to Overcome Tumor Resistancefinanznachrichten.de
2. 2Haolic发布第三代XP-2桌面DTF打印机finanznachrichten.de